Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127012051 | 12701205 | 1 | I | 20160823 | 20160831 | 20160831 | EXP | DE-AMGEN-DEUSP2016111356 | AMGEN | HAGEN BAHLMANN. GM-CSF AS SUCCESSFUL SALVAGE THERAPY OF METAMIZOLE (DIPYRONE)-INDUCED AGRANULOCYTOSIS WITH FOURNIER^S GANGRENE AND SEVERE SEPTIC SHOCK IN AN ADOLESCENT. CLINICAL CASE REPORTS. 2016;4(8):816-819 | 14.00 | YR | T | F | Y | 0.00000 | 20160830 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127012051 | 12701205 | 1 | PS | NEUPOGEN | FILGRASTIM | 1 | Unknown | AT A DOSE UP TO 18 MCG/KG/DAY FOR 8 DAYS | 103353 | UNKNOWN FORMULATION | |||||||||
| 127012051 | 12701205 | 2 | SS | METAMIZOLE | METAMIZOLE | 1 | Unknown | FREQUENTLY WITH 3 G/DAY (40 MG/KG BODY WEIGHT IN THREE SINGLE DOSES, MAXIMUM 5 G/DAY) | 0 | ||||||||||
| 127012051 | 12701205 | 3 | SS | METAMIZOLE | METAMIZOLE | 1 | 0 | ||||||||||||
| 127012051 | 12701205 | 4 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | UP TO 17.5 MCG/KG/MIN | 0 | |||||||||||
| 127012051 | 12701205 | 5 | C | MEROPENEM. | MEROPENEM | 1 | 3 G/DAY | 0 | 3 | G | QD | ||||||||
| 127012051 | 12701205 | 6 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 20 MG/KG/DAY | 0 | 20 | MG/KG | QD | ||||||||
| 127012051 | 12701205 | 7 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 30 MG/KG/DAY | 0 | 30 | MG/KG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127012051 | 12701205 | 1 | Agranulocytosis |
| 127012051 | 12701205 | 2 | Wound complication |
| 127012051 | 12701205 | 3 | Impaired healing |
| 127012051 | 12701205 | 4 | Blood pressure management |
| 127012051 | 12701205 | 5 | Pseudomonas infection |
| 127012051 | 12701205 | 6 | Pseudomonas infection |
| 127012051 | 12701205 | 7 | Pseudomonas infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127012051 | 12701205 | HO |
| 127012051 | 12701205 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127012051 | 12701205 | Agranulocytosis | |
| 127012051 | 12701205 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |